Skip to main content

Advertisement

SpringerLink
Log in

Women and Heart Failure: An Emerging Venus-Mars Concept

  • Women and Heart Disease (J Robinson, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

Some of the most profound sex differences in cardiovascular disease are evident in the syndrome of heart failure. Certain heart failure conditions have a unique predilection for women, such as heart failure with preserved ejection fraction and apical ballooning syndrome; or are exclusive to women, such as peripartum cardiomyopathy. Overall, there are notable differences between women and men in terms heart failure disease burden, risk factors, clinical presentation and prognosis. Yet, women remain under-represented in heart failure clinical trials. Important knowledge gaps exist in our understanding of the pathophysiologic basis for these sex differences and potential for effective sex-specific management strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Velagaleti RS, Gona P, Larson MG, et al. Multimarker approach for the prediction of heart failure incidence in the community. Circulation. 2010;122:1700–6.

    Article  PubMed  Google Scholar 

  2. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics−−2012 Update: a report from the American Heart Association. Circulation. 2012;125:e2–220.

    Article  PubMed  Google Scholar 

  3. Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–2594.

    Article  PubMed  CAS  Google Scholar 

  4. Borlaug BA, Redfield MM. Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation. 2011;123:2006–14.

    Article  PubMed  Google Scholar 

  5. Hsich EM, Pina IL. Heart failure in women: A need for prospective data. J Am Coll Cardiol. 2009;54:491–8.

    Article  PubMed  Google Scholar 

  6. Rho RW, Patton KK, Poole JE, et al. Important differences in mode of death between men and women with heart failure who would qualify for a primary prevention implantable cardioverter-defibrillator. Circulation. 2012;126:2402–7.

    Article  PubMed  Google Scholar 

  7. •• Martinez-Selles M, Doughty RN, Poppe K, et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012;14:473–9. This meta-analysis represents the largest assessment of the association of sex and heart failure survival rates.

    Article  PubMed  Google Scholar 

  8. Hsich EM, Grau-Sepulveda MV, Hernandez AF, et al. Sex differences in in-hospital mortality in acute decompensated heart failure with reduced and preserved ejection fraction. Am Heart J. 2012;163(3):430–7.

    Article  PubMed  Google Scholar 

  9. •• Scantlebury DC, Borlaug BA. Why women are more likely then men to develop heart failure with preserved ejection fraction? Curr Opin Cardiol. 2011;26:562–8. Why women are more likely then men to develop heart failure with preserved ejection fraction?.

    Article  PubMed  Google Scholar 

  10. Fujimoto N, Borlaug BA, Lewis GD, et al. Hemodynamic responses to rapid saline loading: the impact of age, sex, and heart failure. Circulation. 2013;127(1):55–62.

    Article  PubMed  CAS  Google Scholar 

  11. Piro M, Della Bona R, Abbate A, et al. Sex-related differences in myocardial remodeling. J Am Coll Cardiol. 2010;55:1057–65.

    Article  PubMed  CAS  Google Scholar 

  12. Petrov G, Regitz-Zagrosek V, Lehmkuhl E, et al. Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation. 2010;122(11 Suppl):S23–8.

    Article  PubMed  Google Scholar 

  13. De Simone G, Devereux RB, Chinali M, et al. Sex differences in obesity related changes in left ventricular morphology: the strong heart study. J Hypertens. 2011;29:1431–8.

    Article  PubMed  Google Scholar 

  14. Rossi P, Frances Y, Kingwell BA, et al. Gender differences in artery wall biomechanical properties throughout life. J Hypertens. 2011;29:1023–33.

    Article  PubMed  CAS  Google Scholar 

  15. Borlaug BA. Sex, load and relaxation; are women more susceptible to load-dependent diastolic dysfunction? J Am Coll Cardiol. 2011;57:1234–6.

    Article  PubMed  Google Scholar 

  16. •• Borlaug BA, Paulus WJ. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J. 2011;32(6):670–9. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

    Article  PubMed  Google Scholar 

  17. • Lam CS, Donal E, Kraigher-Krainer E, et al. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13(1):18–28. This article gives a comprehensive review of the current epidemiology trends and clinical course and disease outcomes of HFpEF.

    Article  PubMed  Google Scholar 

  18. Melander O, Maisel AS, Almgren P, et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA. 2012;308(14):1469–75.

    Article  PubMed  CAS  Google Scholar 

  19. • Lam CS, Carson PE, Anand IS, et al. Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the i-preserve trial. Circ Heart Fail. 2012;5(5):571–8. This article represents the largest and most representative study of HFpEF with a sex-specific analysis and outcomes.

    Article  PubMed  CAS  Google Scholar 

  20. Looi JL, Wong CW, Khan A, et al. Clinical characteristics and outcome of apical ballooning syndrome in Auckland, New Zealand. Heart Lung Circ. 2012;21(3):143.

    Article  PubMed  Google Scholar 

  21. Brinjikji W, El-Sayed AM, Salka S. In-hospital mortality among patients with takotsubo cardiomyopathy: a study of the National Inpatient Sample 2008 to 2009. Am Heart J. 2012;164(2):215–21.

    Article  PubMed  Google Scholar 

  22. • Eitel I, von Knobelsdorff-Brekenhoff F, Bernhardt P, et al. Clinical characteristics and CV magnetic resonance findings in stress (Takotsubo) cardiomyopathy. JAMA. 2011;306:277–86. This article describes the clinical characteristics of ABS is a large multicenter cohort, and has the largest magnetic resonance imaging series of ABS to date.

    Article  PubMed  CAS  Google Scholar 

  23. Maron BJ, Towbin JA, Thiene G, et al. American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113(14):1807–16.

    Article  PubMed  Google Scholar 

  24. Deshmukh A, Kumar G, Pant S, et al. Prevalence of Takotsubo cardiomyopathy in the United States. Am Heart J. 2012;164(1):66–71.

    Article  PubMed  Google Scholar 

  25. Cacciotti L, Passaseo I, Marazzi G, et al. Observational study on Takotsubo-like cardiomyopathy: clinical features, diagnosis, prognosis and follow-up. BMJ Open. 2012;2:e001165.

    Article  PubMed  Google Scholar 

  26. • Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol. 2011;58(7):659–70. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management.

    Article  PubMed  Google Scholar 

  27. Sliwa K, Hilfiker-Kleiner D, Petrie MC, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail. 2010;12:767–78.

    Article  PubMed  Google Scholar 

  28. Burlingame J, Horiuchi B, Ohana P, et al. The contribution of heart disease to pregnancy-related mortality according to the pregnancy mortality surveillance system. J Perinatol. 2012;32(3):163–9.

    Article  PubMed  CAS  Google Scholar 

  29. Biteker M, Ilhan E, Biteker G, et al. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J of Heart Fail. 2012;14(8):895–901.

    Article  Google Scholar 

  30. Goland S, Bitar F, Modi K, et al. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail. 2011;17(5):426–30.

    Article  PubMed  Google Scholar 

  31. Biteker M, Duran NE, Kaya H, et al. Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial. Clin Res Cardiol. 2011;100:571–7.

    Article  PubMed  CAS  Google Scholar 

  32. Gevaert S, Van Belleghem Y, Bouchez S, et al. Acute and critically ill peripartum cardiomyopathy and ‘bridge to’ therapeutic options: a single center experience with intra-aortic balloon pump, extra corporeal membrane oxygenation and continuous-flow left ventricular assist devices. Crit Care. 2011;15:R93.

    Article  PubMed  Google Scholar 

  33. Sliwa K, Blauwet L, Tibazarwa K, et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation. 2010;121(13):1465–73.

    Article  PubMed  CAS  Google Scholar 

  34. Ballo P, Betti I, Mangialavori G, et al. Peripartum Cardiomyopathy Presenting with Predominant Left Ventricular Diastolic Dysfunction: Efficacy of Bromocriptine. Case Rep Med. 2012;2012:476903.

    PubMed  Google Scholar 

  35. Safirstein JG, Ro AS, Grandhi S, et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int J Cardiol. 2012;154(1):27–31.

    Article  PubMed  Google Scholar 

  36. Mandal D, Mandal S, Mukherjee D, et al. Pregnancy and subsequent pregnancy outcomes in peripartum cardiomyopathy. J Obstet Gynaecol Res. 2011;37:222–7.

    Article  PubMed  Google Scholar 

  37. Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgrad Med J. 2011;87:34–9.

    Article  PubMed  Google Scholar 

Download references

Funding

CSPL is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore and a L’Oreal Women In Science Award from L’Oreal and UNESCO.

Conflict of Interest

Ting T. Low declares that she has no conflict of interest.

Carolyn S.P. Lam declares that she has no conflict of interest.

Author information

Authors and Affiliations

  1. National University Heart Centre, From the National University Health System, Tower Block Level 9, 1E Kent Ridge Road, Singapore, 119228, Singapore

    Ting T. Low & Carolyn S. P. Lam

Authors
  1. Ting T. Low
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carolyn S. P. Lam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carolyn S. P. Lam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Low, T.T., Lam, C.S.P. Women and Heart Failure: An Emerging Venus-Mars Concept. Curr Cardiovasc Risk Rep 7, 212–216 (2013). https://doi.org/10.1007/s12170-013-0307-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12170-013-0307-z

Keywords

Search

Navigation